Status:
RECRUITING
Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Very Preterm and Extremely Preterm Birth
Anemia
Eligibility:
All Genders
Up to 28 years
Brief Summary
Prematurity affects around 60,000 births a year in France. Extremely premature babies are particularly fragile and require multiple erythrocyte transfusions to maintain an effective hemoglobin level f...
Eligibility Criteria
Inclusion
- age : ≤ 28 days of life
- Premature newborn with term of birth \< 31 weeks hospitalized in intensive care or neonatology intensive care at CHU Amiens-Picardie (CHU-AP) between July 2022 and July 2024, whether born at CHU-AP maternity unit or transferred secondarily
Exclusion
- Newborn with term of birth ≥ 31 weeks and \> 28 days of life
Key Trial Info
Start Date :
March 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06909487
Start Date
March 25 2025
End Date
March 1 2026
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Amiens
Amiens, France, 80054